{"metadata":{"topics":["Accountability","Administrative law","American law","American political philosophy","Amylin","Amylin Pharmaceuticals","Applications of cryptography","Applied ethics","Artificial objects","Authentication","Business","Business economics","Business law","Case law","Civil law (common law)","Civil law (legal system)","Civil rights and liberties","Common law","Communication","Communication design","Companies","Comparative law","Computer security","Constitutional law","Contract","Contract law","Corporate finance","Corporate governance","Corporate law","Corporations","Courts","Covidien","Crime","Criminal justice","Criminal law","Cultural globalization","Culture","Custom","Cyberspace","Data laws","Doctrines","Documents","Drug","Drug policy","Drugs","Economic law","Economy","Economy of the United States","Email","Environmental law","Ethical principles","Executive branch of the United States government","Exenatide","Finance","Financial economics","Financial markets","Government","Government agencies","Government and personhood","Government information","Government of South Africa","Government of the United States","Gram","Health","Health care","Health care companies","Health policy","Health sciences","Healthcare industry","Human activities","Human communication","Human rights","Industries","Information science","Intellectual property law","Intellectual works","International law","International relations","Investment","Jurisprudence","Justice","Kilogram","Law","Law and economics","Law of obligations","Lawsuits","Legal communication","Legal concepts","Legal disputes","Legal doctrines and principles","Legal documents","Legal ethics","Legal literature","Legal procedure","Legal writing","Legislative branch of the United States government","Life sciences industry","Mallinckrodt","Management","Market (economics)","Medical treatments","Medication","Medicinal chemistry","Medicine","Microeconomics","Missouri","Monopoly (economics)","Morality","National security","National supreme courts","Natural resources law","North America","Northrop Grumman B-2 Spirit","Official documents","Open government","Paragraph","Personality traits","Pharmaceutical companies","Pharmaceutical companies of the United Kingdom","Pharmaceutical companies of the United States","Pharmaceutical industry","Pharmaceutical sciences","Pharmaceutics","Pharmacology","Pharmacy","Political charters","Political science","Politics","Politics of the United States","Price","Principles","Privacy","Private law","Products of chemical industry","Professional ethics","Property","Property law","Public administration","Public law","Public policy","Public records","Public sphere","Purchase order","Regulation","Rights","Roman law","Rules","Secrecy","Securities (finance)","Security","Security (finance)","Service industries","Services (economics)","Signature","Social institutions","Social issues","Social policy","Sociological theories","Sources","Sources of law","South African law","St. Louis","Statutory law","Supreme Court of the United States","Supreme court case law","Technology","Theories of law","Understanding","United States","United States Constitution","United States Supreme Court cases","United States case law","United States criminal law","United States federal case law","United States federal courts","United States federal law","United States federal legislation","United States federal policy","United States law","United States lawsuits","United States legislation","United States public law","Value (ethics)","Virtue","Writing","Written communication"],"person_names":["marie berry","tom palmer"],"vars":{},"organization_names":["amylin letterhead","amylin pharmaceuticals","amylin pharmaceuticals inc.","covidien","inc.","mallinckrodt","mcdonnell blvd.","securities and exchange"],"agreement_id":"efa54b45b21070ca2ddc7d1361195940e2d4ebe3d8e2fe110a57b1fc5199951d","terms":["***","***** Confidential Treatment Requested**","*****Text Omitted and Filed Separately with the Securities and Exchange**","***] ([***","**AMYLIN PHARMACEUTICALS, INC.**","**Commission. Confidential Treatment Requested Under**","**EXENATIDE DRUG SUBSTANCE**","**EXHIBIT A**","**MALLINCKRODT INC., a Covidien company**","**[***","**[Forecast Attached]**","“Agreement”","“Amylin”","“Mallinckrodt”"]}}